INSIGHT: Life Sciences Companies Targeted in Securities Class Actions
In 2018, life sciences companies were, once again, popular targets of securities class action lawsuits. Prudent life sciences companies should continue to take heed of the results of the decisions and filings in 2018 to ensure that they are aware of the recent developments in the law as well as filing trends.
There’s no indication the high number of class action securities claims filed against life sciences companies will abate in 2019. Three Dechert LLP attorneys offer best practices companies should consider to reduce the risk of being targeted.